Home » Newsletters » BioWorld Science

BioWorld Science

May 7, 2003

View Archived Issues

New data on the efficacy and safety of vardenafil in erectile dysfunction

S-18886 improves endothelial function in coronary artery disease

Potential noninvasive technique for the detection of Alzheimer's disease

Boehringer Ingelheim presents new cathepsin inhibitors with utility in autoimmune diseases

Porphyrin-based photosensitizers for use in ocular disorders, cancer, etc.

Novel neurotrophic agents prepared and tested at Ortho-McNeil

Schering patent covers new CDK and/or GSK-3beta inhibitors

Bayer researchers describe new PPARalpha agonists and their use in coronary heart disease

Antitumor apoptolidin derivative with enhanced stability

Analgesic agents with neurotensin NT2 receptor-antagonist activity

Roche scientists prepare and test novel COX-2 inhibitors

CytRx expands RNAi collaboration with Massachusetts medical school

Yamanouchi licenses PYM-50028 rights for Japan

Phase I trial of HER-2 Protein AutoVac cleared to begin

Elan: Q1 developments

First-quarter results reported by Aventis

InterMune offers review of Q1 highlights

FDA grants accelerated approval of Iressa for NSCLC

Viventia's first armed antibodies to enter phase I clinical testing

Positive preclinical results reported for new treatment for sepsis

Roscovitine inhibits the proliferation of RPE cells

Cell adhesion inhibitor K-7174 exerts beneficial effects in murine model of Sjogren's syndrome

U.S. approval for Cialis anticipated for second half of 2003

Further positive results from FluINsure challenge study

Riquent NDA filing planned

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 10, 2026.
Cas and effect: Merck’s phase III ripples HIF-2α space
BioWorld
Oddsmakers wasted no time figuring the market chances after Merck & Co. Inc. rolled out data from the phase III Litespark-011 study testing its oral...
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 10, 2026
MSD synthesizes α-synuclein PET agents
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has prepared and tested new positron emission tomography (PET) agents for binding and imaging α-synuclein (SNCA) for the diagnosis...